Biopharmaceutical Drug Discovery
Enterprises involved in therapeutic antibody R&D are choosing Geneious Biologics and Geneious Prime to narrow the search for successful candidates and innovate faster.
Commercial Life Sciences
Organizations working in a wide range of sectors such as pharma, diagnostics, and agroscience use Geneious Prime to improve the efficiency of teams and unlock the value of sequence data.
Academic and Government Research
Students, academics, and government professionals use Geneious Prime in a multitude of research disciplines, due to the comprehensive nature of its operations.
A History of Helping Scientists Innovate
“We created Geneious tools because we didn’t want our bright scientific minds spending 80 percent of their time doing basic data management. So we thought, if we can take away the pain and complexity of data computation and allow them to focus on what they’re really good at – which is understanding what that data means to uncover new scientific knowledge – then we’ve done our job.”
— Brett Ammundsen, Chief Executive Officer
December 10, 2018
Fairjourney Biologics ‘Future-Proofs’ Therapeutic Antibody Discovery With Geneious Biologics
November 27, 2018
Geneious Biologics’ Future Role in Next Generation Sequencing (NGS) Presented at Antibody Engineering & Therapeutics Conference
November 12, 2018
VIB Accelerates Therapeutic Biologics Discovery with Geneious Biologics